Board Of Management

NixxaMed’s Board of Management consists of 4 members who drive the company toward its vision and draw general road map for the company. The board approves the company’s strategic plan and annual budgeting and monitors the company’s outcomes in a large picture and yearly basis. Board of Management is responsible to align company’s pathway with all other members of “Iran Consertia of Dialysis”. Consortia members routinely holds joint meeting among all management boards of member companies to exchange views and make necessary collaborative decisions. Following provides a brief introduction to our Board of Management members:

Dr. Rambod Hajipour, MD & MBA
Chairman of Board

As Chairman of Management Board, Rambod Hajipour is responsible to provide general directions and coordinate any new ideas presented to the Nixxamed board. He is also responsible to provide intra-companies coordination among the members of Concerti (Iranian Consortium of Dialysis) to achieve optimum activity alignment and maximum group productivity and ensure best achievement of group business objectives. His proven record and respective experience in medical field, especially more than ten years of successful management in Meditechsys Inc. have provide Nixxamed and all rest of Consertia member companies with a valuable source of leadership and strategic decision makeing.

Dr. Maryam Sadeghalvad, MD & PHD
Member of Board

Dr. Sadegalvad has over 20 years of field experience in medical and surgical practice. Her understanding of the needs of patients, doctors, nurses, hospitals authorities and other stakeholders has been instrumental for the board to develop a robust communication and network development strategies among the health care community. In addition to that, her experience in clinical investigation is an asset to Nixxamed in order to introduce its products to the market and pass clinical trial stages efficiently. As a member of Board, not only her experience but also her creative ideas have always been a fuel to the board decisions and standpoints.

Dr. Nozar Mortazavi, MD
Member of Board (Representing Meditechsys Inc.)

Dr. Mortazavi, utilizes his many years of experience in management, and productive collaboration with internal teams in various level company in Meditechsys to ensure the growth and stability of Nixxamed. He is the deputy of CEO and Senior Executive in Meditechsys and has been engaged in many key projects in Meditechsys development history. His bright academic background and many years of experience in research has been a valuable asset to Nixxamed scientific approach to new opportunities.

Ramin Hajipour Sanknani, B.Sc. And MBA
Member of Board and Chief Executive Officer (CEO)

Under Ramin Sanknani leadership as Chief Executive Officer, Nixxamed will continue to focus on execution, driving top line growth and improving profitability and cash flow. He oversees the executive team and is responsible for the Nixxamed activity based on the approaved road map while maintaining the quality and performance of the company.His many years of experience in management, Research, Technical Development with proven track records in respective fields of expertise will help Nixxamed move faster and safer toward its goals and to ensure the growth and stability of Nixxamed.

A Message from CEO (Need More Enhancement)

NixxaMed’s Board of Management consists of 4 members who drive the company toward its vision and draw general road map for the company. The board approves the company’s strategic plan and annual budgeting and monitors the company’s